Profund Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$291K	Buy	8,015 +1,065	+15%	+$47.6K	0.01%	764
2025 Q4	$324K	Sell	6,950 -3,141	-31%	-$140K	0.01%	815
2025 Q3	$420K	Sell	10,091 -9,606	-49%	-$307K	0.01%	584
2025 Q2	$566K	Sell	19,697 -2,220	-10%	-$68.6K	0.02%	435
2025 Q1	$735K	Buy	21,917 +5,032	+30%	+$188K	0.03%	370
2024 Q4	$863K	Sell	16,885 -3,176	-16%	-$178K	0.03%	322
2024 Q3	$1.03M	Sell	20,061 -1,406	-7%	-$72.5K	0.04%	317
2024 Q2	$962K	Sell	21,467 -12,816	-37%	-$592K	0.04%	308
2024 Q1	$1.6M	Sell	34,283 -5,851	-15%	-$229K	0.06%	207
2023 Q4	$1.43M	Buy	40,134 +6,308	+19%	+$193K	0.06%	254
2023 Q3	$1.01M	Buy	33,826 +8,230	+32%	+$170K	0.06%	280
2023 Q2	$461K	Buy	25,596 +1,193	+5%	+$23.8K	0.02%	540
2023 Q1	$392K	Buy	+24,403	New	+$452K	0.02%	597